Back to results
US 8,946,392 B2Granted
Gemcitabine immunoassay
AssigneeSaladax Biomedical Inc.
InventorsSalvatore J. Salamone, Jodi Blake Courtney, Howard Sard, Christopher Spedaliere
Life of this patent
Estimating the term…
Abstract
The present invention comprises novel conjugates and immunogens derived from gemcitabine and unique antibodies generated by using gemcitabine linked immunogens, which conjugates immunogens and antibodies, are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids.
Claims11
An antibody which binds selectively to gemcitabine and does not have any substantially cross reactivity to 2′, 2′-difluoro-2′-deoxyuridine and tetrahydrouridine.
Dependencies are inferred from the claim text.